Our Portfolio

University of California, Los Angeles

John Ringman, MD | CA, United States

Project Overview

  • Academic/Nonprofit Organization Type
  • $299,451 Funding Amount
  • 7/1/03 — 11/15/07 Project Duration
  • Drug Discovery Program
  • Clinical Phase 2 Therapeutic Stage
  • Closed Status

University of California, Los Angeles

John Ringman, MD | CA, United States

A Phase II, Double-Blind, Placebo-Controlled Study of the Safety and Tolerability of Three Doses of Curcumin versus Placebo in Patients with Mile to Moderate Alzheimer's Disease

GET IN TOUCH